cupla things
firstly dbs is an immediate and effective amelioration and as @Osgood reflects it does not alter the long-term course of the PD progression
whereas the small trial clearly shows a significant-enough tail away of the effect of PD on some patients from some (80) samples
so these are completely different lenses to view cause and effect of two entirely different treatments
it's like being in a bumper car at the circus versus riding the Ghan ...one is instant crash bang yerr done the other is an imperceptible take off and long run
PD patients are normal people with PD (sorry, it sounds dumb even when i type it!) so the expectations are greater, the perception is to see a significant instance like DBS is like a thirst that needs to be quenched
we can think of the two in opposing directions dbs is a pop leading to a long hiss and NTcell implants are the opposite end of that effect
that's clearly another singular thing that needed to be marketed (effect v affect)
.....and we need a bigger trial (which would demonstrate this exact difference, as subtle as it appears currently)
imho
- Forums
- ASX - By Stock
- 1AI
- Other views
Other views, page-17
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.49M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $291 | 36.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 243367 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 1778841 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 243367 | 0.008 |
12 | 4919787 | 0.007 |
10 | 4486749 | 0.006 |
6 | 2510009 | 0.005 |
4 | 4065000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 1778841 | 10 |
0.010 | 2702788 | 5 |
0.011 | 1490400 | 3 |
0.012 | 330000 | 2 |
0.014 | 170000 | 2 |
Last trade - 14.04pm 30/08/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online